CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss	$ (2,903)	$ (2,544)
Depreciation and amortization	554	411
Stock-based compensation expense	427	364
Fair value loss on convertible note, net	90	0
Inventory LCNRV write-downs and losses on firm purchase commitments	53	220
Other non-cash activities	55	7
Changes in operating assets and liabilities:
Accounts receivable, net	(88)	(239)
Inventory	(125)	(1,190)
Other assets	(63)	(82)
Accounts payable and accrued liabilities	(257)	16
Other liabilities	234	155
Net cash used in operating activities	(2,023)	(2,882)
Cash flows from investing activities:
Purchases of short-term investments	(2,229)	(938)
Maturities of short-term investments	1,671	0
Capital expenditures	(537)	(538)
Net cash used in investing activities	(1,095)	(1,476)
Cash flows from financing activities:
Proceeds from issuance of capital stock including employee stock purchase plan	33	37
Proceeds from issuance of convertible notes	1,000	1,485
Other financing activities	(5)	(5)
Net cash provided by financing activities	1,028	1,517
Effect of exchange rate changes on cash and cash equivalents	(4)	2
Net change in cash	(2,094)	(2,839)
Cash, cash equivalents, and restricted cash—Beginning of period	7,857	12,099
Cash, cash equivalents, and restricted cash—End of period	5,763	9,260
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	365	338
Capital stock issued to settle bonuses	179	137
Right-of-use assets obtained in exchange for operating lease liabilities	$ 87	$ 27